Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 12 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (3)
P 1 (9)

Trial Status

Recruiting5
Completed3
Not Yet Recruiting3
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT07445113Not ApplicableNot Yet RecruitingPrimary

Diaphragmatic Breathing and Stimulation of the Autonomic Nervous System

NCT07251153Phase 1RecruitingPrimary

Pharmacokinetic Comparison of Vonafexor Acid and Its Lysine Salt and Evaluation of Potential Drug-Drug Interactions

NCT07413666Phase 1RecruitingPrimary

A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years

NCT07412080Phase 1CompletedPrimary

EDP167 in Healthy Volunteers and Subjects With Mild Dyslipidemia

NCT07201584Phase 1RecruitingPrimary

A Comparative Bioavailability Study of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fasting Conditions:

NCT07313332Not ApplicableNot Yet RecruitingPrimary

Exploring Resistance Exercise Training Plus High-Intensity Interval Training (ReHIIT) as Cancer Prehabilitation

NCT07269873Phase 1Not Yet RecruitingPrimary

Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol

NCT07221318Not ApplicableRecruitingPrimary

Evaluating a Mat-Based Biometric Vibration System for Sleep and Daily Recovery

NCT06935682Phase 1RecruitingPrimary

Safety and Pharmacokinetics of Y-4 Tablets in Healthy Subjects

NCT04341077Phase 1UnknownPrimary

Study to Evaluate the Safety and Pharmacokinetics of Single-Dose Fluzoparib in Healthy Chinese Subjects

NCT03381664Phase 1CompletedPrimary

Study to Assess the Bioavailability, Pharmacokinetics, Safety, and Tolerability of AVP-923 in Healthy Adult Participants

NCT02650479Phase 1CompletedPrimary

Study of the Effects of Intravenous Exenatide on Cardiac Repolarization

Showing all 12 trials

Research Network

Activity Timeline